توپيرامات تيڤع ٢٠٠ ملغ

Pays: Israël

Langue: arabe

Source: Ministry of Health

Ingrédients actifs:

TOPIRAMATE 200 MG

Disponible depuis:

TEVA PHARMACEUTICAL INDUST.LTD

Code ATC:

N03AX11

forme pharmaceutique:

TABLETS

Mode d'administration:

PER OS

Fabriqué par:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Groupe thérapeutique:

TOPIRAMATE

indications thérapeutiques:

Topiramate Teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. Topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with Lennox-Gastaut syndrome . Topiramate Teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.Topiramate Teva is indicated in adults for the prevention of migraines. The use of Topiramate Teva in the acute treatment of migraine has not been studied .

Date de l'autorisation:

2011-08-01